| NAV | $16.04 | Daily Change | $0.03 | 0.19% |
| Market Price | $16.03 | Daily Change | $0.05 | 0.31% |
RYLD seeks to generate income through covered call writing, which historically produces higher yields in periods of volatility.1
RYLD has made monthly distributions 5 years running.
RYLD writes call options on the Russell 2000 Index, saving investors the time and potential expense of doing so individually.
1Covered call writing can limit the upside potential of the underlying security
| Inception Date | 04/17/19 |
| Gross Expense Ratio | 0.63% |
| Net Expense Ratio* | 0.60% |
| Net Assets | $1.39 billion |
| NAV | $16.04 |
| Fact Sheet | View the document |
*Fee waivers are contractual and in effect until at least March 1, 2025.
The Global X Russell 2000 Covered Call ETF (RYLD) follows a “covered call” or “buy-write” strategy, in which the Fund buys the stocks in the Russell 2000 Index (at times by exposure to the Vanguard Russell 2000 ETF), and “writes” or “sells” corresponding call options on the Russell 2000 Index.
The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.
| Ticker | RYLD |
| Bloomberg Index Ticker | BXR |
| CUSIP | 37954Y459 |
| ISIN | US37954Y4594 |
| Primary Exchange | NYSE Arca |
| Shares Outstanding | 86,380,000 |
| Number of Holdings | 17 |
| 30-Day Median Bid-Ask Spread | 0.06% |
| 30-Day SEC Yield | 0.36% |
| Unsubsidized 30-Day SEC Yield | 0.32% |
| 12-Month Trailing Yield | 13.22% |
| Distribution Yield | 12.20% |
| Distribution Frequency | Monthly |
| NAV | $16.04 | Daily Change | $0.03 | 0.19% |
| Market Price | $16.03 | Daily Change | $0.05 | 0.31% |
|
As of recent (03/31/24)
As of recent (03/31/24)
|
Fund NAV | Market Price | Index |
|---|---|---|---|
| 1 Year | 5.83% | 6.07% | 6.72% |
| 3 Years | 0.11% | 0.03% | 0.82% |
| Since Inception | 3.77% | 3.77% | 4.58% |
| 1 Year | 2.98% | 2.85% | 3.75% |
| 3 Years | -2.26% | -2.34% | -1.65% |
| 5 Years | 4.03% | 3.97% | 4.74% |
| Since Inception | 3.31% | 3.27% | 4.11% |
| Year-to-Date | 3.99% | 4.11% | 4.15% |
| 1 Month | 3.34% | 3.52% | 3.45% |
| 3 Months | 3.99% | 4.11% | 4.15% |
| Since Inception | 20.14% | 20.15% | 24.89% |
| Year-to-Date | 2.26% | 2.20% | 2.50% |
| 1 Month | 0.89% | 0.70% | 1.16% |
| 3 Months | 1.62% | 1.62% | 1.81% |
| Since Inception | 18.15% | 17.95% | 22.91% |
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.
| Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
|---|---|---|---|---|---|---|
| 86.41 | RSSL | GLOBAL X RUSSELL 2000 ETF | BR3T756 | 79.89 | 14,955,986 | 1,194,833,721.54 |
| 15.83 | VTWO | VANGUARD RUSSELL 2000 ETF | B48MJP3 | 81.97 | 2,670,392 | 218,892,032.24 |
| 0.19 | CASH | 1.00 | 2,614,358 | 2,614,357.83 | ||
| 0.03 | OTHER PAYABLE & RECEIVABLES | 1.00 | 451,221 | 451,220.78 | ||
| 0.00 | CINCOR PHARMA INC - CVR | BMGS153 | 3.06 | 15,984 | 48,911.04 | |
| 0.00 | PLSE | PULSE BIOSCIENCES INC | BD02SG8 | 11.19 | 1,148 | 12,846.24 |
| 0.00 | INHIBRX INC - CVR | BK1MBC3 | 0.65 | 15,798 | 10,268.70 | |
| 0.00 | NOVARTIS AG - CVR | 0.39 | 26,043 | 10,156.77 | ||
| 0.00 | CZFS | CITIZENS FINL SV | 2651592 | 44.94 | 17 | 751.40 |
| 0.00 | 2200963D | EARNOUT SHS 12.50 | 0.02 | 2,421 | 48.42 | |
| 0.00 | 2200964D | EARNOUT SHS 15.00 | 0.02 | 2,421 | 48.42 | |
| 0.00 | SBCF | SEACOAST BANKING CORP/FL | BH65L93 | 19.00 | 0 | 0.19 |
| 0.00 | SUM | SUMMIT MATERIA-A | BW9JPS4 | 0.00 | 0 | 0.15 |
| 0.00 | 2324462D | CARTESIAN THERA -CVR | BM9HFX3 | 0.13 | 1 | 0.13 |
| 0.00 | STR | SITIO ROYALTIES CORP-A | BMF9G85 | 0.00 | 0 | 0.07 |
| 0.00 | OABI | OMNIAB INC | BN13S71 | 4.00 | 0 | 0.04 |
| 0.00 | BRKL | BROOKLINE BANCORP INC | 2967675 | 0.00 | 0 | 0.03 |
| -2.47 | RUT US 07/19/24 C2020 | 4,935.00 | -6,909 | -34,095,915.00 | ||
| 2445568D US | DANIMER SCIENTIFIC INC -W | 0.00 | 0 |
Investing involves risk, including the possible loss of principal. Investments in smaller companies typically exhibit higher volatility. Concentration in a particular industry or sector will subject RYLD to loss due to adverse occurrences that may affect that industry or sector. Investors in RYLD should be willing to accept a high degree of volatility in the price of the fund’s shares and the possibility of significant losses.
RYLD engages in options trading. An option is a contract sold by one party to another that gives the buyer the right, but not the obligation, to buy (call) or sell (put) a stock at an agreed upon price within a certain period or on a specific date. A covered call option involves holding a long position in a particular asset, in this case U.S. common equities, and writing a call option on that same asset with the goal of realizing additional income from the option premium. RYLD writes covered call index options on the Russell 2000 Index. By selling covered call options, the fund limits its opportunity to profit from an increase in the price of the underlying index above the exercise price, but continues to bear the risk of a decline in the index. A liquid market may not exist for options held by the fund. While the fund receives premiums for writing the call options, the price it realizes from the exercise of an option could be substantially below the indices current market price. Investment in the Fund is subject to the risks of the underlying fund.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by FTSE Russell or Cboe, nor do these entities make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with these entities.